Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Ponte, C, Craven, A, Robson, J, Grayson, P, Suppiah, R, Watts, R, Merkel, P, Luqmani, R
Format:	Conference item
Wydane:	2013

Podobne zapisy

REVIEW OF THE EXPERT PANEL METHODOLOGY IN THE DIAGNOSTIC AND CLASSIFICATION CRITERIA FOR VASCULITIS STUDY: A PILOT STUDY
od: Pante, C, i wsp.
Wydane: (2014)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
od: Craven, A, i wsp.
Wydane: (2013)

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
od: Seeliger, B, i wsp.
Wydane: (2017)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
od: Luqmani, R, i wsp.
Wydane: (2011)

The need for diagnostic criteria in systemic vasculitis
od: Suppiah, R, i wsp.
Wydane: (2011)

Classification criteria for the anca-associated vasculitides
od: Robson, J, i wsp.
Wydane: (2019)

Systemic vasculitis--is it time to reclassify?
od: Watts, R, i wsp.
Wydane: (2011)

Assessment of damage in vasculitis: Expert ratings of damage
od: Seo, P, i wsp.
Wydane: (2008)

Assessment of damage in vasculitis: expert ratings of damage.
od: Seo, P, i wsp.
Wydane: (2009)

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
od: Suppiah, R, i wsp.
Wydane: (2022)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
od: Grayson, P, i wsp.
Wydane: (2022)

Cutaneous manifestations of ANCA-associated vasculitis
od: Chiesafuxench, Z, i wsp.
Wydane: (2016)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
od: Pearce, F, i wsp.
Wydane: (2016)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
od: Grayson, PC, i wsp.
Wydane: (2022)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
od: Pearce, F, i wsp.
Wydane: (2017)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
od: Floris, A, i wsp.
Wydane: (2016)

Outcome measures in ANCA-associated vasculitis.
od: Suppiah, R, i wsp.
Wydane: (2010)

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
od: Micheletti, R, i wsp.
Wydane: (2017)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
od: Ponte, C, i wsp.
Wydane: (2022)

Assessment of damage in vasculitis: expert ranking of items of damage
od: Seo, P, i wsp.
Wydane: (2007)

Advances in the classification of primary systemic vasculitis
od: Suppiah, R, i wsp.
Wydane: (2009)

284 Differences in early damage patterns in various forms of primary systemic vasculitis
od: Wawrzycka-Adamczyk, K, i wsp.
Wydane: (2016)

Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study
od: Monti, S, i wsp.
Wydane: (2018)

Using the Birmingham Vasculitis Activity Score as a Screening Tool in Patients with Suspected Vasculitis
od: Floris, A, i wsp.
Wydane: (2016)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
od: Ponte, C, i wsp.
Wydane: (2022)

OP0055 Using the Birmingham Vasculitis Activity Score as a screening tool in patients with suspected vasculitis
od: Floris, A, i wsp.
Wydane: (2016)

Reply
od: Grayson, PC, i wsp.
Wydane: (2022)

American College of Rheumatology and European League Against Rheumatism 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis
od: Grayson, PC, i wsp.
Wydane: (2017)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
od: McLaren, J, i wsp.
Wydane: (2003)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
od: Suppiah, R, i wsp.
Wydane: (2011)

Treatment of vasculitis in rheumatoid arthritis.
od: Luqmani, R, i wsp.
Wydane: (1994)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
od: Suppiah, R, i wsp.
Wydane: (2011)

Predictors of renal involvement in ANCA associated vasculitis
od: Kronbichler, A, i wsp.
Wydane: (2018)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
od: Suppiah, R, i wsp.
Wydane: (2011)

The United Kingdom and Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm – associated vasculitis and giant cell arteritis
od: Luqmani, R, i wsp.
Wydane: (2017)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
od: Luqmani, R, i wsp.
Wydane: (2017)

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
od: Merkel, P, i wsp.
Wydane: (2011)

Clinical features and structured clinical evaluation of vasculitis
od: Ponte, C, i wsp.
Wydane: (2018)

Vasculitis: an update.
od: Luqmani, R
Wydane: (2014)

Vasculitis: an update.
od: Luqmani, R
Wydane: (2014)